3-113291580-C-CTT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM4PP5
The NM_001164496.2(CFAP44):c.5541_5542insAA(p.Glu1848LysfsTer41) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,537,108 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (no stars).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
CFAP44
NM_001164496.2 frameshift
NM_001164496.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.131
Genes affected
CFAP44 (HGNC:25631): (cilia and flagella associated protein 44) Enables peptidase activity. Involved in sperm axoneme assembly. Acts upstream of or within microtubule cytoskeleton organization. Predicted to be located in cytoplasm; cytoskeleton; and motile cilium. Implicated in spermatogenic failure 20. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Frameshift in the end of transcript resulting in stoplost. Downstream stopcodon found after 1848 codons.
PP5
Variant 3-113291580-C-CTT is Pathogenic according to our data. Variant chr3-113291580-C-CTT is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3352580.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFAP44 | NM_001164496.2 | c.5541_5542insAA | p.Glu1848LysfsTer41 | frameshift_variant | 35/35 | ENST00000393845.9 | |
LOC127898559 | NR_183046.1 | n.8177_8178insAA | non_coding_transcript_exon_variant | 48/48 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFAP44 | ENST00000393845.9 | c.5541_5542insAA | p.Glu1848LysfsTer41 | frameshift_variant | 35/35 | 5 | NM_001164496.2 | P2 | |
CFAP44 | ENST00000484923.1 | n.673_674insAA | non_coding_transcript_exon_variant | 2/2 | 4 | ||||
CFAP44 | ENST00000461734.1 | c.*231_*232insAA | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | 2 | ||||
CFAP44 | ENST00000489244.1 | c.*464_*465insAA | 3_prime_UTR_variant, NMD_transcript_variant | 4/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152180Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
31
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000215 AC: 31AN: 144364Hom.: 0 AF XY: 0.0000908 AC XY: 7AN XY: 77086
GnomAD3 exomes
AF:
AC:
31
AN:
144364
Hom.:
AF XY:
AC XY:
7
AN XY:
77086
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000151 AC: 209AN: 1384928Hom.: 0 Cov.: 29 AF XY: 0.000139 AC XY: 95AN XY: 683390
GnomAD4 exome
AF:
AC:
209
AN:
1384928
Hom.:
Cov.:
29
AF XY:
AC XY:
95
AN XY:
683390
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74330
GnomAD4 genome
AF:
AC:
31
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CFAP44-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2024 | The CFAP44 c.5540_5541dupAA variant is predicted to result in a frameshift and premature protein termination (p.Glu1848Lysfs*41). This variant has been reported in the homozygous state in an individual with multiple morphological abnormalities of the flagella (Coutton et al. 2019. PubMed ID: 30686508). This variant is reported in 0.056% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in CFAP44 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at